A groundbreaking five-minute "super-jab" is poised to benefit thousands of cancer patients in England, with the potential to ...

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the ...

Heart attacks remain a significant health concern in the United States. According to the Centers for Disease Control and ...

The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of ...

Silo Pharma reported positive preclinical results for its ketamine-based implant SP-26, designed to treat chronic pain and ...

A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within ...

The jab is an injectable form of the immunotherapy drug nivolumab, which can be used to treat 15 cancer types, including skin ...